Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice:
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen ; Nürnberg
Friedrich-Alexander-Universität Erlangen-Nürnberg
2023
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV048873452 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 230323s2023 gw |||| o||u| ||||||eng d | ||
| 015 | |a 23,O04 |2 dnb | ||
| 016 | 7 | |a 128297517X |2 DE-101 | |
| 024 | 7 | |a 10.1177/17562864211058298 |2 doi | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-218017 |2 urn | |
| 035 | |a (OCoLC)1374570739 | ||
| 035 | |a (DE-599)DNB128297517X | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |8 3\p |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |8 2\p |a 610 |2 23sdnb | ||
| 084 | |8 1\p |a 615.3 |2 23ksdnb | ||
| 100 | 1 | |a Rieckmann, Peter |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |c Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
| 264 | 1 | |a Erlangen ; Nürnberg |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2023 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a cladribine tablets | ||
| 653 | |a consensus | ||
| 653 | |a COVID-19 | ||
| 653 | |a disease-modifying drugs | ||
| 653 | |a relapsing multiple sclerosis | ||
| 653 | |a vaccination | ||
| 700 | 1 | |a Centonze, Diego |e Verfasser |4 aut | |
| 700 | 1 | |a Giovannoni, Gavin |e Verfasser |4 aut | |
| 700 | 1 | |a Hua, Le H. |e Verfasser |4 aut | |
| 700 | 1 | |a Oreja-Guevara, Celia |e Verfasser |4 aut | |
| 700 | 1 | |a Selchen, Daniel |e Verfasser |4 aut | |
| 700 | 1 | |a Soelberg Sørensen, Per |e Verfasser |4 aut | |
| 700 | 1 | |a Vermersch, Patrick |e Verfasser |4 aut | |
| 700 | 1 | |a Wiendl, Heinz |e Verfasser |4 aut | |
| 700 | 1 | |a Salloukh, Hashem |e Verfasser |4 aut | |
| 700 | 1 | |a Yamout, Bassem |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t Therapeutic Advances in Neurological Disorders |g Vol. 14 (2021) |o 10.1177/17562864211058298 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-218017 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://d-nb.info/128297517X/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |q application/pdf |u https://open.fau.de/handle/openfau/21801 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-034138319 | ||
| 347 | |b PDF | ||
| 883 | 0 | |8 1\p |a emakn |c 0,09889 |d 20230311 |q DE-101 |u https://d-nb.info/provenance/plan#emakn | |
| 883 | 0 | |8 2\p |a emasg |c 0,83334 |d 20230311 |q DE-101 |u https://d-nb.info/provenance/plan#emasg | |
| 883 | 1 | |8 3\p |a npi |d 20230310 |q DE-101 |u https://d-nb.info/provenance/plan#npi | |
Datensatz im Suchindex
| _version_ | 1804185012301463552 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Rieckmann, Peter Centonze, Diego Giovannoni, Gavin Hua, Le H. Oreja-Guevara, Celia Selchen, Daniel Soelberg Sørensen, Per Vermersch, Patrick Wiendl, Heinz Salloukh, Hashem Yamout, Bassem |
| author_facet | Rieckmann, Peter Centonze, Diego Giovannoni, Gavin Hua, Le H. Oreja-Guevara, Celia Selchen, Daniel Soelberg Sørensen, Per Vermersch, Patrick Wiendl, Heinz Salloukh, Hashem Yamout, Bassem |
| author_role | aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Rieckmann, Peter |
| author_variant | p r pr d c dc g g gg l h h lh lhh c o g cog d s ds s p s sp sps p v pv h w hw h s hs b y by |
| building | Verbundindex |
| bvnumber | BV048873452 |
| collection | ebook |
| ctrlnum | (OCoLC)1374570739 (DE-599)DNB128297517X |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02897nmm a2200649zc 4500</leader><controlfield tag="001">BV048873452</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">230323s2023 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">23,O04</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">128297517X</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1177/17562864211058298</subfield><subfield code="2">doi</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-218017</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1374570739</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB128297517X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">2\p</subfield><subfield code="a">610</subfield><subfield code="2">23sdnb</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="8">1\p</subfield><subfield code="a">615.3</subfield><subfield code="2">23ksdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Rieckmann, Peter</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice</subfield><subfield code="c">Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen ; Nürnberg</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cladribine tablets</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">consensus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">COVID-19</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disease-modifying drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">relapsing multiple sclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vaccination</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Centonze, Diego</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Giovannoni, Gavin</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hua, Le H.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Oreja-Guevara, Celia</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Selchen, Daniel</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soelberg Sørensen, Per</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vermersch, Patrick</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wiendl, Heinz</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salloukh, Hashem</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yamout, Bassem</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">Therapeutic Advances in Neurological Disorders</subfield><subfield code="g">Vol. 14 (2021)</subfield><subfield code="o">10.1177/17562864211058298</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-218017</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://d-nb.info/128297517X/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="q">application/pdf</subfield><subfield code="u">https://open.fau.de/handle/openfau/21801</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034138319</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="b">PDF</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">emakn</subfield><subfield code="c">0,09889</subfield><subfield code="d">20230311</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emakn</subfield></datafield><datafield tag="883" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">emasg</subfield><subfield code="c">0,83334</subfield><subfield code="d">20230311</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#emasg</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">npi</subfield><subfield code="d">20230310</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#npi</subfield></datafield></record></collection> |
| id | DE-604.BV048873452 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T21:44:29Z |
| indexdate | 2024-07-10T09:48:28Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034138319 |
| oclc_num | 1374570739 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Rieckmann, Peter Verfasser aut Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout Erlangen ; Nürnberg Friedrich-Alexander-Universität Erlangen-Nürnberg 2023 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager cladribine tablets consensus COVID-19 disease-modifying drugs relapsing multiple sclerosis vaccination Centonze, Diego Verfasser aut Giovannoni, Gavin Verfasser aut Hua, Le H. Verfasser aut Oreja-Guevara, Celia Verfasser aut Selchen, Daniel Verfasser aut Soelberg Sørensen, Per Verfasser aut Vermersch, Patrick Verfasser aut Wiendl, Heinz Verfasser aut Salloukh, Hashem Verfasser aut Yamout, Bassem Verfasser aut Sonderdruck aus Therapeutic Advances in Neurological Disorders Vol. 14 (2021) 10.1177/17562864211058298 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-218017 Resolving-System kostenfrei Volltext https://d-nb.info/128297517X/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext application/pdf https://open.fau.de/handle/openfau/21801 Verlag kostenfrei Volltext 1\p emakn 0,09889 20230311 DE-101 https://d-nb.info/provenance/plan#emakn 2\p emasg 0,83334 20230311 DE-101 https://d-nb.info/provenance/plan#emasg 3\p npi 20230310 DE-101 https://d-nb.info/provenance/plan#npi |
| spellingShingle | Rieckmann, Peter Centonze, Diego Giovannoni, Gavin Hua, Le H. Oreja-Guevara, Celia Selchen, Daniel Soelberg Sørensen, Per Vermersch, Patrick Wiendl, Heinz Salloukh, Hashem Yamout, Bassem Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
| title | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
| title_auth | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
| title_exact_search | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
| title_exact_search_txtP | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
| title_full | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
| title_fullStr | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
| title_full_unstemmed | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout |
| title_short | Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice |
| title_sort | expert opinion on covid 19 vaccination and the use of cladribine tablets in clinical practice |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-218017 https://d-nb.info/128297517X/34 https://open.fau.de/handle/openfau/21801 |
| work_keys_str_mv | AT rieckmannpeter expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT centonzediego expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT giovannonigavin expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT hualeh expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT orejaguevaracelia expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT selchendaniel expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT soelbergsørensenper expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT vermerschpatrick expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT wiendlheinz expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT salloukhhashem expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice AT yamoutbassem expertopiniononcovid19vaccinationandtheuseofcladribinetabletsinclinicalpractice |